A study developed and validated a stereoselective HPLC method to determine the enantiomers of lenalidomide, an oral immune modulating drug, in both its bulk and capsule forms. The stability-indicating method can detect lenalidomide in the presence of its degradation products. The method was validated for accuracy, precision, linearity, range, specificity, limit of detection, limit of quantification and robustness according to ICH guidelines.